Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction

NCT07146360 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction (MI)

Interventions

BIOLOGICAL: Revelise (GENERIUM, Russia)
BIOLOGICAL: Actilyse® (Boehringer Ingelheim Pharma GmbH and Co.KG, Germany)

Sponsor

AO GENERIUM